当前位置:首页 - 行情中心 - 神州细胞(688520) - 财务分析 - 现金流量表

神州细胞

(688520)

  

流通市值:183.39亿  总市值:193.68亿
流通股本:4.45亿   总股本:4.70亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金376,514,303.961,725,605,641.841,309,082,892.53878,508,789.27
  收到的税费返还88,544.5749,182,974.0749,005,230.248,653,447.15
  收到其他与经营活动有关的现金2,442,053.12131,586,636.019,059,239.365,720,801.97
  经营活动现金流入小计379,044,901.651,906,375,251.921,367,147,362.09932,883,038.39
  购买商品、接受劳务支付的现金100,892,701.06477,314,224.73337,514,864.37227,517,394.86
  支付给职工以及为职工支付的现金156,689,568.42715,282,895.84552,898,080.14394,233,321.73
  支付的各项税费8,737,043.1473,002,599.3253,837,763.2337,184,464.35
  支付其他与经营活动有关的现金205,612,253.65916,377,288.41729,717,090.43480,069,246.97
  经营活动现金流出小计471,931,566.272,181,977,008.31,673,967,798.171,139,004,427.91
  经营活动产生的现金流量净额-92,886,664.62-275,601,756.38-306,820,436.08-206,121,389.52
二、投资活动产生的现金流量:
  收回投资收到的现金650,000,0001,690,000,0001,130,000,000720,000,000
  取得投资收益收到的现金780,049.482,508,219.151,748,227.621,231,090.86
  投资活动现金流入小计650,780,049.481,692,508,219.151,131,748,227.62721,231,090.86
  购建固定资产、无形资产和其他长期资产支付的现金86,733,460.81216,517,898.77166,106,189.33109,212,553.05
  投资支付的现金700,000,0001,767,970,510.731,313,970,510.73733,970,510.73
  投资活动现金流出小计786,733,460.811,984,488,409.51,480,076,700.06843,183,063.78
  投资活动产生的现金流量净额-135,953,411.33-291,980,190.35-348,328,472.44-121,951,972.92
三、筹资活动产生的现金流量:
  吸收投资收到的现金896,000,000565,000,00065,000,000-
  取得借款收到的现金214,437,829.422,386,519,7401,771,155,437.141,192,858,437.24
  筹资活动现金流入小计1,110,437,829.422,951,519,7401,836,155,437.141,192,858,437.24
  偿还债务支付的现金206,461,173.181,789,474,962.191,000,107,292.86795,811,511.52
  分配股利、利润或偿付利息支付的现金20,296,291.51111,830,872.179,195,181.5646,968,728.51
  支付其他与筹资活动有关的现金540,931.9827,176,331.7220,080,233.8712,952,422.56
  筹资活动现金流出小计227,298,396.671,928,482,166.011,099,382,708.29855,732,662.59
  筹资活动产生的现金流量净额883,139,432.751,023,037,573.99736,772,728.85337,125,774.65
四、汇率变动对现金及现金等价物的影响3,134.43-58,686.45-59,520.03-50,916.78
五、现金及现金等价物净增加额654,302,491.23455,396,940.8181,564,300.39,001,495.43
  加:期初现金及现金等价物余额770,330,864.6314,933,923.79314,933,923.79314,933,923.79
  期末现金及现金等价物余额1,424,633,355.83770,330,864.6396,498,224.09323,935,419.22
补充资料:
  净利润--566,202,185.71--33,858,151.29
  资产减值准备-19,642,764.22-11,524,437.59
  固定资产和投资性房地产折旧-132,843,564.09-63,175,818.05
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-132,843,564.09-63,175,818.05
  无形资产摊销-22,009,794.88-9,006,519.6
  长期待摊费用摊销-14,608,190.25-7,314,355.45
  处置固定资产、无形资产和其他长期资产的损失--5,814.16--
  固定资产报废损失--56,044.65--57,854.59
  公允价值变动损失--10,323,313.36--14,590,195.22
  财务费用-88,997,866.54-41,951,607.02
  投资损失--1,253,907.51--366,004.48
  递延所得税-2,580,828.34--
    递延所得税负债增加-2,580,828.34--
  存货的减少--83,384,704.4--58,370,452.73
  经营性应收项目的减少-174,258,043.8--142,376,408.4
  经营性应付项目的增加--34,936,186.73--2,347,580.04
  其他--63,955,983.04--106,158,042.17
  现金的期末余额-770,330,864.6-323,935,419.22
  减:现金的期初余额-314,933,923.79-314,933,923.79
  现金及现金等价物的净增加额-455,396,940.81-9,001,495.43
公告日期2026-04-302026-04-232025-10-312025-08-29
审计意见(境内)标准无保留意见
TOP↑